Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-732-6 | CAS number: 10339-55-6
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Ethyllinalool, linalool (CAS 78-70-6) and dehydrolinalool (CAS 29717-20-8) are structurally related substances having similar chemical structures. Their physical-chemical properties are comparable and available experimental data on the same toxicological endpoints, showed identical toxicological properties. This is applicable also to the genetic toxicity and therefore a read-across it justified.
Overall, mutagenicity and genotoxicity testing was unremarkable. All three substances were negative in the Ames test. Linalool and dehydrolinalool were negative in an in vivo micronucleus test. Linalool was also negative in an in vitro chromosome aberration test and in an in vitro forward mutation testing. Although dehydrolinalool was positive in the in vitro chromosomal aberration test in the absence of metabolic activation, the next higher Tier test i.e. the in vivo MNT in the bone marrow was clearly negative.
Short description of key information:
In vitro
- Gene mutation in bacteria (Bacterial Reverse Mutation Assay/Ames): not mutagenical substances
- Cytogenicity test (Mammalian Chromosome Aberration): not clastogenic (for linalool); clastogenic without metabolic activation (dehydrolinalool).
- Mammalian cell gene mutation assay (Mouse Lymphoma Forward Mutation) not mutagenic (linalool)
In vivo
- Cytogenicity test (Mammalian Erythrocyte Micronucleus Test): not mutagenic (linalool and dehydrolinalool).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Overall, mutagenicity and genotoxicity testing was unremarkable. Therefore, it can be concluded that the substance is not mutagenic and therefore does not need to be classified for mutagenicity according to the criteria outlined in 1272/2008/EC (CLP/EU-GHS).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
